Although some previous reports showed the discordance of EGFR mutation between primary and metastatic tumors27, 28, further studies with large sample sizes and studies utilizing the high throughput technology of whole exome sequencing demonstrated that driver events, such as EGFR and BRAF mutations, were highly consistent between primary and metastatic tumors. The gene discussed is EGFR; the disease is metastatic neoplasm.